Folke Per-Olof Wallström

Folke Per-Olof Wallström is the founder of Arosia Communication AB. He currently holds the position of Chairman at Camurus AB, Chairman at Arosgruppen Fastigheter Fjärdingen AB, Chairman at Camurus Development AB, and Deputy Director at Reabyran AB. Previously, he served as the Chief Executive Officer of Q-Med AB, President & Chief Executive Officer of Karo Healthcare AB, Chief Executive Officer of Melacure Therapeutics AB, and Chief Executive Officer of Karobio Usa.
He has also held various chairman positions at AROSGRUPPEN Holding AB, Aros Arkitekter AB, Nexttobe AB, Patients Pending Ltd., Aggal Invest AB, Mb Erikssons Bygg & Fastighet AB, Chemilia AB, and Masmastaren Fjardingen AB. Additionally, he served as a Director at Swedish Orphan International Holding AB and Envirotainer AB. He was an Independent Director at Hansa Biopharma AB from 2011 to 2018 and is currently a Director at Q-linea AB. He has also served as a Director at Mediplast AB and NeoDynamics AB, as well as Deputy Director at Addcode Design AB and Patients Pending AB. He has a graduate degree from the University of Uppsala.